GOLDMAN SACHS GROUP INC - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 39 filers reported holding ACORDA THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$5,928,000
+77.3%
6,080,0000.0%0.00%0.0%
Q4 2020$3,344,000
-35.8%
6,080,0000.0%0.00%0.0%
Q3 2020$5,208,000
-1.0%
6,080,0000.0%0.00%
-50.0%
Q2 2020$5,261,000
-0.7%
6,080,0000.0%0.00%0.0%
Q1 2020$5,296,000
+15.9%
6,080,0000.0%0.00%
+100.0%
Q4 2019$4,570,000
-3.9%
6,080,0000.0%0.00%0.0%
Q3 2019$4,757,000
-6.8%
6,080,000
+1.3%
0.00%0.0%
Q2 2019$5,104,000
+163.8%
6,000,000
+199.7%
0.00%0.0%
Q2 2018$1,935,000
+23.8%
2,002,000
-2.7%
0.00%
Q4 2016$1,563,000
-17.0%
2,057,000
-10.8%
0.00%
-100.0%
Q3 2016$1,882,000
+10970.6%
2,307,000
+12042.1%
0.00%
Q1 2016$17,000
-99.7%
19,000
-99.6%
0.00%
-100.0%
Q4 2014$4,927,000
-13.6%
4,282,000
-22.1%
0.00%0.0%
Q3 2014$5,701,0005,495,0000.00%
Other shareholders

There were no reported owners of ACORDA THERAPEUTICS INC in Q3 2016.

NameSharesValueWeighting ↓
View complete list of ACORDA THERAPEUTICS INC shareholders